LIVN's Quality Score fell 1 point on Thu, Nov 5, to 19.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 18% on Nov 4, a up day for the market: the S&P 500 rose 2%, 71% of stocks rose, and medical device stocks a median 7%.
| Free cash flow quadrupled | $43.4M → $173.3M in 3 years |
| Latest filing | 8-K, Nov 4 |
ReportYesterday morning: sales of $393.1M. Raised its outlook for the year. Past reports ›
Mon Nov 9: UBS Global Healthcare Conference 2026Investor conference · date confirmed.
3 more dates ahead: conferences, for Pro members.
After its last 4 reports it closed +6.6% on average, higher 3 of 4 times.
Excellentfor quality, not price, 7 of 14 chart checks firingWhat the Quality Score means
Well above its recent run. LIVN scores 19 today, against a median of 12 over its last 20 recorded sessions.
LIVN is #2 of 85 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score |
Share count against a year before: LIVN +0.7%, ITGR -2.9%.
Expected to report Wed Feb 24, before the open (in 111 days). Expected.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $393.1M, 10% more than a year ago.
“Third-quarter 2026 Cardiopulmonary revenue increased 10.9% on a reported basis and 10.9% on a constant-currency basis versus the third quarter of 2025 with growth across all regions, driven by strong consumables demand and Essenz™ Perfusion System sales, as well as favorable realized price.”
LIVN's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Revenue growth, constant currency | 9% to 10% |
Sales grew 8.2% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 2.3% a year over 5 years.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Nov 4, 2026 | +12.2% | +17.9% | open |
| Aug 5, 2026 | -6.4% | -8.4% | -7.9% |
| May 6, 2026 | +5.9% | +15.1% | +24.6% |
Sales grew in four of the last seven years, to $1.4B in 2025. It lost money in 2025 after a profit in 2024.
3 insiders sold $1M across 6 filings in the last 6 months. No open-market buys on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
“LivaNova competes in the global medical device market with sales in more than 100 countries.”
LIVN scores 19 today, which Breakaway calls Excellent. It is #2 of 85 in Medical Devices by Quality Score, with 7 of 14 chart checks firing. Up 18% on Nov 4, a up day for the market: the S&P 500 rose 2%, 71% of stocks rose, and medical device stocks a median 7%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
LIVN scores 19 today, which Breakaway calls Excellent (15 to 19). That is #2 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind LIVN's 19.
3 insiders sold $1M across 6 filings in the last 6 months. No open-market buys on record. The newest is Francesco Bianchi, Director, who sold $273K on Sep 10. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.